Extract notice to the Minister
Omlyclo (nouvelle teneur)
Common name / Subject : omalizumab
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : 150 mg/ml (2 ml)
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : 150 mg/ml (2 ml)
Indication : Urticaire chronique idiopathique (nouvelle teneur)
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
À venir
Evaluation published on April 29, 2026
INESSSid: 29914
Recevable on February 02, 2026